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 Summary Statement 
We show that partial loss of function mutations in the Idh3a gene lead to retinal 
degeneration due to compromised mitochondrial function.  Complete loss of Idh3a, 
however, is embryonically lethal. 
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 Abstract 
Isocitrate dehydrogenase (IDH) is an enzyme required for the production of α-
ketoglutarate from isocitrate. IDH3 generates the NADH used in the mitochondria for 
ATP production, and is a tetramer made up of two α, a β and a γ subunit. Loss of 
function and missense mutations in both IDH3A andIDH3B have previously been 
implicated in families exhibiting retinal degeneration. Using mouse models we have 
investigated the role of IDH3 in retinal disease and mitochondrial function. 
 
We identified mice with late-onset retinal degeneration in a screen of ageing mice 
carrying an ENU-induced mutation, E229K, in Idh3a. Mice homozygous for this 
mutation exhibit signs of retinal stress, indicated by GFAP staining, as early as 3 
months, but no other tissues appear to be affected. We produced a knockout of Idh3a 
and found that homozygous mice do not survive past early embryogenesis. Idh3a-/E229K 
compound heterozygous mutants exhibit a more severe retinal degeneration when 
compared to Idh3aE229K/E229K. Analysis of mitochondrial function in mutant cell lines 
highlighted a reduction in mitochondrial maximal respiration and reserve capacity 
levels in both Idh3aE229K/E229K and Idh3a-/E229K cells. Loss-of function Idh3b mutants do 
not exhibit the same retinal degeneration phenotype, with no signs of retinal stress or 
reduction in mitochondrial respiration. 
 
It has been previously reported that the retina operates with a limited mitochondrial 
reserve capacity and we suggest that this, in combination with the reduced reserve 
capacity in mutants, explains the degenerative phenotype observed in Idh3a mutant 
mice. 
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 Introduction 
 
Mitochondrial diseases are highly diverse: over 220 different genes have been 
identified which can cause diseases of the mitochondria and these diseases have a 
wide range of pathologies (Koopman et al., 2012). Common to many of the diseases, 
however, are neurological or neuromuscular manifestations, including retinal disease. 
We have identified a missense mutation in the gene encoding a subunit of the 
tricarboxylic acid (TCA) cycle enzyme isocitrate dehydrogenase 3 (IDH3) as causing a 
retinal degeneration phenotype in mice. There are three isocitrate dehydrogenase 
isozymes in mammals. IDH1 and IDH2 are both homodimers that catalyse the 
decarboxylation of isocitrate to α-ketoglutarate with the concomitant reduction of 
NADP to NADPH. IDH1 is cytoplasmic whilst IDH2 is localised to the mitochondria. No 
inherited disease has been associated with IDH1 mutations, but mutations in IDH2 
cause a metabolic disease, D-2-Hydroxyglutaric Aciduria, with a range of features 
including epilepsy, hypotonia and other neurological manifestations(Kranendijk et al., 
2010). IDH1 or 2 are found to be mutated in a high proportion of glioblastomas and 
other tumours of the nervous system. By contrast, IDH3 is a heterotetramer, 
composed of two alpha, a beta, and a gamma subunits, encoded by three genes. IDH3 
is located in the mitochondria where the conversion of isocitrate to α-ketoglutarate is 
necessary for the TCA cycle to progress and generates NADH, which feeds into 
oxidative phosphorylation to generate ATP. No recurrent mutations in any of the IDH3 
genes have been described in tumours. 
 
A number of patients have been described with a variety of mutations in IDH3A 
(Fattal-Valevski et al., 2017; Pierrache et al., 2017). The most severe of these, a 
homozygous missense mutation (p.Pro304His), exhibited neurological defects from 
birth, possibly due to a failure during development, as well as retinal degeneration.  
The patient however showed no symptoms of muscle weakness typically associated 
with mitochondrial deficiencies.  The remaining patients, with biallelic variants, all 
exhibited childhood onset of retinal degeneration, and some had pseudocoloboma of 
the macula.  Pseudocoloboma is not a developmental defect but is due to 
degeneration of the retina.   Seven different alleles were found in four different 
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 families all predicted to be pathogenic – including two which could potentially cause 
nonsense mediated decay.  The other five, all missense mutations, are anticipated to 
be damaging.  Two families with homozygous mutations in IDH3B, and which exhibited 
non-syndromic retinal degeneration, have also been described previously (Hartong et 
al., 2008).  None of these patients showed symptoms of mitochondrial dysfunction 
other than retinitis pigmentosa.  
 
We have identified a missense mutation, E229K, in mouse Idh3a which is associated 
with late-onset retinal degeneration. In addition we generated a complete loss-of-
function mutation in this gene and show that it is early embryonic lethal. This 
mutation, when combined with the missense mutation Idh3aE229K results in a more 
rapid retinal degeneration than the missense homozygotes. Photoreceptors of the 
retina have a particularly high energy requirement, and the mitochondria of these 
cells function at 70-80% of their maximal rate, leaving limited reserve capacity 
(Kooragayala et al., 2015). This most likely accounts for the sensitivity of the retina to 
mitochondrial mutations. On the other hand, a loss of function mutation in Idh3b is 
viable and has no detectable abnormal phenotype. The retina of these mice are 
normal up to 6 months of age. We have analysed the mitochondrial function in cells 
with Idh3 mutations and find the maximum and reserve capacity of Idh3a mutant cells 
to be reduced. However, cells lacking IDH3B show no detectable mitochondrial defect. 
 
 
  
Results 
 
Following a screen for ENU-induced recessive mutations with an age-dependent 
phenotype, we identified a mouse line which exhibited loss of vision and retinal 
degeneration associated with increasing age (Potter et al., 2016). When subjected to 
a moving visual stimulus within an optokinetic drum (OKD) at 12 months of age, a 
subset of the littermates in this cross responded with the stereotypical head 
movement only at ~0.2 cycles per degree (c/d), compared to >0.3 c/d for 
phenotypically wildtype littermates. These mice maintained a diminished response at 
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 18 months (Fig. 1A). The same mice had abnormal retina, identified by indirect 
ophthalmoscopy and documented by fundal imaging at 7 months (Fig. 1B). The dark 
patches on the retinal images are indicative of retinal degeneration. No other overt 
phenotypes were detected in the mice up to 18 months of age ( Table S1). 
 
Genotyping of the affected littermates in this cross revealed a single common region 
of homozygosity on chromosome 9, between 50.1 and 74.8 Mb. Analysis of whole 
genome sequence of the founder male for this line found two candidate protein 
coding mutations in the interval, heterozygous in the founder; sorting nexin 33 (Snx33) 
and the alpha subunit of Isocitrate Dehydrogenase 3 (Idh3a). The Snx33 mutation was 
not present in the mutant line, presumably as it is on the unaffected chromosome. 
We considered the missense mutation, E229K in Idh3a, to be the likely causative 
mutation, as human patients with mutations in either IDH3A or B exhibit retinal 
degeneration (Fattal-Valevski et al., 2017; Hartong et al., 2008; Pierrache et al., 2017). 
To confirm Idh3a as the causative gene we used CRISPR/Cas9 to introduce a loss-of-
function mutation. We generated an insertion of 5bp into exon 7 of the gene, 
c.702_703InsGTACT, termed Idh3aem1Jkn, abbreviated herein as Idh3a-. 
 
We bred compound heterozygous mice for Idh3a- and Idh3aE229K and examined their 
eyes and visual function. As documented below these mice have rapid retinal 
degeneration, demonstrating lack of complementation between the two alleles, and 
indicating that the E229K mutation is the cause of retinal degeneration in the mice 
found in the screen. 
 
Structural analysis of missense mutations 
Residue Glu229 is located at the rim (Levy, 2010) of the heterodimeric interface 
formed between IDH3A and IDH3G (Fig. 1C), contributing only a small amount of 
surface area (9.7 Å2) to the much larger interface (4401 Å2). However, molecular 
modelling of the E229K mutation, which replaces a negatively charged side chain with 
a positive charge, shows that it is likely to moderately disrupt the IDH3A:IDH3G 
interaction with little effect on the stability of the IDH3A monomer (Fig. 1D). In 
contrast, all five of the previous identified damaging IDH3A mutations are located 
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 away from the interface, either in the protein interior (A175V, M239T, P304H, M313T) 
or on the protein surface (R316C). All of these mutations are predicted to destabilize 
the IDH3A monomer, but not the interaction with IDH3G. 
 
Loss of IDH3A is lethal 
As IDH3 is a critical part of the mitochondrial tricarboxylic acid (TCA) cycle, we asked 
whether the loss-of-function insertion allele was compatible with life. We intercrossed 
mice carrying the Idh3a- allele. No homozygous mice were recovered at weaning from 
a total of 120 genotyped, indicating that a complete loss of function of Idh3a is lethal. 
We examined embryos from intercrosses at different stages.  No homozygous 
embryos were recovered at embryonic day (E) 10.5 or E12.5.  At E8.5 only remains of 
developmentally delayed embryos were recovered, indicating lethality to be early in 
development (Table 1).  We confirmed loss of function of Idh3a by Western blot 
analysis of Idh3a-/+ and Idh3a-/E229K mutant embryonic fibroblasts which showed a 
reduction in Idh3a protein when compared to Idh3a+/+, Idh3aE229K/+, Idh3aE229K/E229K cell 
lines (Fig. S1).  Heterozygous littermates were aged to one year but no retinal 
degeneration was observed indicating that one functional allele of the gene is 
sufficient (Fig. S2). 
 
Onset of retinal degeneration is early and rapid 
We analysed the onset and progression of the retinal degeneration of both 
Idh3aE229K/E229K and Idh3a-/E229K mice by immunostaining for glial fibrillary acidic 
protein (GFAP), expression of which is a sign of reactive gliosis of the Müller cells and 
an early indicator of stress within  the retina (Eisenfeld et al., 1984). We also stained 
histological sections to assess retinal structure and integrity.  From post natal day 30 
(P30), Idh3a-/E229K mice exhibit GFAP staining throughout the retina (Fig. 2A), 
highlighting intermediate fibrils protruding from the ganglion cell layer to the outer 
nuclei layer (ONL). Nevertheless, at this stage Idh3a-/E229K mice still retain the same 
number of nuclei in the ONL, the nuclei of the photoreceptors, as control littermates 
(Fig. 2C) throughout almost the entire retina with only a slight decrease in the nasal 
periphery. However, by P60 the ONL has lost a significant portion of nuclei indicating 
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 a loss in photoreceptor cells (Fig. 2B).  This loss progresses further by P90 (Fig. 2B). No 
other cells within the retina appear to be lost during this degeneration.   
By contrast, Idh3aE229K/E229K mice up to P60 show no signs of reactive gliosis or loss of 
cells (Fig. 2A). It is not until P90 that they begin to show GFAP staining (Fig. 2 A), and 
the mice begin to lose photoreceptor nuclei (Fig. 2D). Again no other cells appear to 
be lost during this time. 
 
Prior to the loss of photoreceptors mice exhibit normal retinal function.   
We carried out electroretinography (ERG) analysis of Idh3a-/E229K mice at P30. Although 
some reactive gliosis is detected at this stage, they nevertheless showed a normal 
response to light stimulus.  A-wave amplitudes are not significantly different to wild 
type and heterozygous (Idh3a-/+ and Idh3aE229K/+) littermates shown by One-way 
ANOVA (F(3,10) = 0.7970, p = 0.5232) and the trace produced shows no abnormalities 
(Figs. 3A & C).  The same mice tested at P60 showed a significantly reduced a-wave 
response by One-way ANOVA with Tukey post hoc tests (F(3,9) = 32.66, p < 0.0001) 
and mice exhibited a flatline ERG trace (Figs. 3B & C).  The loss of a scotopic response 
is concurrent with the loss of photoreceptors observed in Fig. 2B. 
The scotopic ERG responses of Idh3aE229K/E229K mice were tested at P60.  Homozygous 
mutants showed no significant difference (p = 0.9604) when compared to wild type 
littermates, showing a normal a-wave amplitude and trace (Figs. 3D & F).  However, 
by 4 months of age the a-wave amplitudes of scotopic ERG responses have 
significantly reduced in Idh3aE229K/E229K compared to wild type litter mates (p = 0.0491 
Unpaired T test with Welch’s correction) (Figs. 3E & F). 
 
Mitochondria show a reduced maximal and reserve capacity 
As IDH3 is an essential part of the mitochondrial TCA cycle, we investigated how the 
Idh3a mutations affected the overall function of mitochondria (Fig. 4A). It has been 
previously shown (Kooragayala et al., 2015) that photoreceptors have a high oxygen 
demand and in consequence their mitochondria are at maximum capacity. In order to 
measure the mitochondrial function in cells that are not already at maximum capacity 
we derived multiple, independent fibroblast lines from Idh3aE229K/E229K and Idh3a-/E229K 
embryos, and heterozygous and wild-type littermates. When tested, the homozygous 
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 and compound heterozygous mutant cell lines showed a trend to lower basal (Fig. 4D), 
ATP (Fig. 4E) and leaked respiration (Fig. 4F), although not statistically significant. 
However, both Idh3aE229K/E229K and Idh3a-/E229K cell lines did exhibit a significant 
decrease in maximal respiration (Fig. 4B) and spare respiratory capacity (Fig. 4C).  
Spare respiratory capacity (SRC) is a direct measure of a cell’s ability to deal with 
respiratory stress.  Mitochondrial dysfunction can result in cell death due to oxidative 
stress. We asked if the mitochondrial defect in this case led to an excess of reactive 
oxygen species in the cells; we found no difference between mutant and wild type 
cells (Fig. S3A).  Similarly we measured the amount of mitochondrial proteins (Fig. 
S3B) and all cell lines showed similar amounts indicating no change in mitochondrial 
number. 
 
Idh3b mutants do not exhibit the same phenotype as Idh3a mutants 
As human patients with apparent loss-of-function mutations in IDH3B seem only to 
have retinal degeneration, we produced a CRISPR Cas9-induced mutation in the 
mouse Idh3b gene. We identified an 8bp deletion allele, c.478_487delCCAATGGA, and 
intercrossed carriers of this mutation, here abbreviated to Idh3b-. Homozygous 
animals were identified at normal Mendelian ratio. 
Protein extracts from homozygous livers were probed on immunoblot following 
electrophoresis and no protein could be detected, indicating the mutation is a loss of 
function (Fig. 5F).  
Idh3b-/- mice were aged and analysed in the same manner as Idh3a mutant mice.  By 
P180 we observed no signs of retinal degeneration.  There is no observed upregulation 
of GFAP when compared to wild type littermate controls (Fig. 5A).  ERG analysis 
showed that homozygous mutants exhibited normal scotopic responses (Fig. 5B).  
Extracellular flux analysis of fibroblasts produced from mutant embryos also showed 
that these mutant cell lines’ mitochondria were not affected by the loss of Idh3b with 
normal reserve capacity and maximum respiration levels (Figs. 5C-E).  
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Discussion 
 
In this study we investigate the retinal degeneration in a mouse line identified in a 
recessive ENU screen.  This is the first mouse model of IDH3A-related chronic retinal 
degeneration described, and closely mirrors the phenotype observed in patients. 
However, is not possible to model the pseudocoloboma of the macula seen in human 
patients in mice, as they lack a macula. Through the course of the investigation we 
confirmed the genetic source of the phenotype to be a missense mutation in the Idh3a 
gene.  The amino acid mutated in the Idh3aE229K mouse is within the highly conserved 
nucleotide binding domain observed in both NAD- and NADP- dependent 
dehydrogenases of animals, including C. elegans and Drosophila(Pierrache et al., 
2017).  E229 is close to the amino acid critical for binding the divalent cation necessary 
for activity (D233), and is within a short segment of beta-sheet (Ma et al., 2017b). 
 
Mutation of such a highly conserved amino acid residue, in an important part of the 
enzyme might suggest that it would cause complete loss of function, but the fact that 
the insertion (null) mutation is embryonic lethal indicates that the E229K allele is 
actually a partial loss of function mutation. The human mutations that have been 
identified in patients with retinitis pigmentosa (RP) presumably also include partial 
loss of function alleles. Two mutations are clear nulls; a frameshift and a stop-gained. 
Each of these is in a compound heterozygote with a likely partial loss of function 
mutation: M239C and R316H. One patient is homozygous for A175V, again presumed 
to be a partial loss of function. A further patient was compound heterozygous for 
M313T and P304H. The latter mutation was also identified as homozygous in a child 
with severe neurological defects in addition to retinal degeneration, and thus M313T 
is another likely partial loss of function allele. The three patients with one clear null 
allele included both who had macular pseudocoloboma in addition to RP, suggesting 
that it is a further reduction in IDH3A activity that results in the additional pathology.  
Notwithstanding the variation in severity of the mutations, all the mutated amino 
acids are completely conserved across animals from mammals to Drosophila and 
C.elegans. Structural modelling suggests that all 5 human mutations destabilize the 
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 protein and thus we suggest cause severe loss, but not complete absence, of this 
catalytic subunit. 
 
Mice compound heterozygous for the missense and insertion mutations exhibited a 
severe form of retinal degeneration, but have no other detectable abnormal 
phenotypes.  A single copy of the Idh3aE229K allele provides sufficient IDH3 function for 
apparently normal development and physiology, except in the photoreceptors. 
As previously reported (Kooragayala et al., 2015), photoreceptor cells operate at 
about 70-80% of their mitochondria’s maximal capacity which means they have little 
to no reserve capacity to use when under metabolic respiratory stress.  Idh3aE229K/E229K 
and Idh3a-/E229K embryonic fibroblasts have a much lower maximal and reserve 
capacity compared to control cells.  This lowered reserve capacity of mutant 
mitochondria combined with the already decreased reserve capacity of photoreceptor 
cells may explain the non-syndromic retinal degeneration phenotype observed.  Much 
like the human patients previously reported, mice with the more severe allele 
combined with the missense allele exhibit a more severe form of degeneration, 
although extracellular flux analysis shows that cells have a similar decrease in reserve 
and maximal respiration.   
 
By using MEF cells the mitochondrial function of mutant mice was observed in an 
unstressed system.  Although the mice showed no overt phenotype other than retinal 
degeneration, their mitochondria in MEFs exhibited a significant reduction of spare 
respiratory capacity.  Reduction of spare respiratory capacity has previously been 
shown to induce cell death in both neurons and cardio myocytes (Pfleger et al., 2015; 
Yadava and Nicholls, 2007).  This reduction is thought to induce cell death either by 
increasing the amount of reactive oxygen species until a threshold is met and the cells 
succumb or causing a reduction in the amount of ATP produced by the electron 
transport chain, caused by a decrease in the availability of substrates (Sansbury et al., 
2011; Yadava and Nicholls, 2007).  Both of these could explain the degenerative 
phenotype observed in the Idh3a mutant mice, within which the catalytic sub unit 
of the Idh3 enzyme has reduced or partial function.   
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 The presence of more than one IDH enzyme within the mitochondria has been used 
as evidence for redundant function  and the viability of human patients apparently 
lacking IDH3B function led others to suggest that it is IDH2 that is the main Krebs Cycle 
enzyme in all tissues except the retina (Hartong et al., 2008).  As we have shown that 
loss of Idh3a is lethal early in development, it is clear that IDH2 cannot compensate, 
and it is the difference between loss of the catalytic subunit and the regulatory subunit 
that that results in the different outcomes. Furthermore, we used RT-PCR to confirm 
the expression Idh2 in the mouse retina, as well as all three subunits of Idh3, (Fig. S1) 
indicating that it is not lack of IDH2 in the retina that results in retinal degeneration. 
On the other hand, when Idh3a activity was knocked down in INS-1 832/13 beta cells, 
glucose dependent production of α-ketoglutarate was greater than when both Idh3a 
and Idh2 were knocked down (MacDonald et al., 2013).  This indicates that IDH2 can 
at least partially make up for the loss of IDH3 in this assay.  A compensatory 
mechanism for loss of IDH3 potentially would be the conversion of NADPH, produced 
by IDH2, to NADH by the enzyme nicotinamide nucleotide transhydrogenase 
(NNT)(Hoek and Rydström, 1988). This NADH would then be able to participate on 
oxidative phosphorylation as normal. Furthermore, the gene encoding NNT is mutated 
in the C57BL6/J strain(Mekada et al., 2009). However, we bred the mice in this study 
with C57BL6/N, with a normal Nnt gene before backcrossing and selecting study 
animals that did not have the mutant Nnt gene.  The lethality of the Idh3a knock out 
allele indicates that NNT is unable to enable compensation in vivo.  
 
In contrast to Idh3a mutants, Idh3b mutant mice are fully viable, and show no signs of 
retinal degeneration within six months of age. Histology and ERG analysis show no 
significant loss of retinal structure or function.  This is also shown in the results of 
extracellular flux analysis whereby Idh3b mutant embryonic fibroblasts cells do not 
show compromised mitochondrial activity. The human patients with clear null 
mutations in IDH3B develop RP in adulthood; the mutant mice may not live long 
enough to develop retinal degeneration, or this may simply reflect species differences. 
Species differences in response to enzymatic dysfunction could also, of course, impact 
the phenotype of the Idh3a mutations.  The α subunit of IDH3, encoded by Idh3a, is 
responsible for the catalytic activity (Bzymek and Colman, 2007).  The alpha subunit 
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 alone is inactive and requires the beta and gamma subunits, encoded by Idh3b and 
Idh3g.  Dimers of αγ or αβ have activity, but vary greatly in their properties. In vitro, 
αγ dimers have 36% the specific activity of the heterotetramer, whilst αβ dimers have 
only 16%. Furthermore, αγ dimers are activated at low concentrations of ATP, whilst 
αβ dimers are inhibited. The substrate, isocitrate, activates both the heterotetramer 
and the αγ dimers,  but has no effect on the αβ dimers (Ma et al., 2017b). We believe 
the catalytic activity of the αγ heterodimers explains the lack, or perhaps delay, of a 
degenerative phenotype in Idh3b mutant mice.  This also explains why loss of function 
IDH3B patients exhibit milder symptoms and at a much later age than patients with 
IDH3A mutations. In addition, the E229K mutation we describe here is likely to be 
interfering with the α/ɣ interaction, indicating that this is important for full activity. 
 
Mutation of many different mitochondrial protein-coding genes can each lead to 
inherited diseases, with a range of phenotypes. Although there are some common 
phenotypic consequences, principal being neurological manifestations, there is no 
clear pattern that can predict the outcome of a particular gene mutation(Munnich, 
2008; Rustin et al., 1997). Even amongst genes of the TCA cycle, there is a range of 
consequences. Some mutations in the mitochondrial aconitase gene (ACO2), similar 
to IDH3A, can result in severe neurological disease, progressive optic atrophy and 
retinal degeneration(Metodiev et al., 2014), whilst other mutations in the same gene 
can give optic atrophy only. Progressive neurodegenerative disease also arises from 
mutations in the gene for the TCA cycle enzyme α-ketoglutarate dehydrogenase. 
Succinate dehydrogenase (SDHA) mutations not only can result in the severe 
neurological disorder Leigh Syndrome, but also in one extended family can cause 
dilated cardiomyopathy. Mutations in the gene for another succinate dehydrogenase 
subunit (SDHD) are also a cause of encephalomyopathy. Muscle involvement in 
addition to neurological disease is also seen in mutations of the malate 
dehydrogenase gene, MDH2.   
 
The high energy demand of the nervous system, and in particular the retina, makes 
these cells particularly sensitive to deficiencies in mitochondrial function. In our novel 
mouse models we show that total loss of the TCA cycle enzyme IDH3 is early 
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 embryonic lethal, indicating that the mitochondrial enzyme IDH2 cannot compensate. 
However, partial loss of function, modelling human patients, results only in retinal 
degeneration. Modelling human patient mutations in which Idh3b, the regulatory 
subunit of IDH3, is absent does not result in retinal degeneration in mice within 6 
months of age, reflecting the later onset of RP in the patients. The mechanism of cell 
death in this and other mitochondrial retinopathies is not fully understood and it 
remains to be addressed whether therapeutic options exist. 
 
Materials and Methods 
 
Mice 
 Idh3ampc201H, here denoted Idh3aE229K, mice were produced in a recessive ENU screen 
at MRC Harwell (Potter et al., 2016).  Idh3aem1Jkn mice were made by microinjection of 
nuclear CRISPR Cas9 nickase vectors px335 together containing two guide RNAs 
targeting exon 7 (Table 2) to minimise off target effects. Sequencing identified a 5bp 
insertion mutation, c.702_703InsGTACT, in the gene.  
Idh3bem1Jkn mice were made by microinjection of CRISPR gRNA targeting exon 5 and 
Cas9 protein into the pronucleus of fertilised eggs (Table 2). Sequencing identified an 
8bp deletion mutation, c.478_487delCCAATGGA, in the gene. gRNA were chosen with 
low off target predictions and mice were back crossed onto C57BL6/J prior to 
breeding. All animal work was approved by a University of Edinburgh internal ethics 
committee and was performed in accordance with the institutional guidelines under 
license by the UK Home Office. 
Immunohistochemistry 
Mice were culled and eyes were enucleated and placed into Davidson’s fixative for 1 
hour (cryosectioning) or overnight (wax embedding).  For cryosectioning eyes were 
removed from Davidson’s fixative and placed into 10%, 15% and 20% sucrose in PBS 
for 15 mins, 15 mins and overnight respectively.  Eyes were then embedded using OCT 
cryopreservant and kept at -80°C until sectioned.  For wax preservation eyes were 
removed from Davidson’s fix and placed successively into 70%, 80%, 90% and 100% 
ethanol, xylene twice and then paraffin each for 45 mins.  
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 Heamatoxylin and Eosin staining was performed on 8 µm paraffin tissue sections and 
imaged on Zeiss Axioplan 2 Brightfield microscope. Glial Fibrillary Acidic Protein 
(GFAP) antibody (ab7260, Abcam) and Alexa Fluor 488 donkey anti-rabbit antibody 
(A21206, Invitrogen) were used on 8 µm frozen sections 1:100 and 1:300 
respectively.Slides were imaged on a Nikon A1R microscope.  
Generation of Mouse Embryonic Fibroblast cells 
Mouse embryonic fibroblast (MEF) cells were generated using E12.5 – 14.5 embryos 
as described in (Takahashi and Yamanaka, 2006) using Gibco Opti-MEM media 
(Thermo Fisher) with 10% Fetal Calf Serum and grown in hypoxic conditions (5% CO2, 
3% O2).  Cells were passaged three times before use, and littermate controls were 
used where possible. 
Electroretinogram 
All mice undergoing an ERG were dark adapted for at least 2 hours prior to the 
procedure, and experiments were carried out in a darkened room under red light 
using an HMsERG system (Ocuscience).  Mice were anesthetized using isofluorane and 
pupils were dilated through the topical application of 1% w/v tropicamide before 
being placed on a heated ERG plate.  Three grounding electrodes were used 
subcutaneously (tail, and each cheek) and silver embedded electrodes were placed on 
the cornea held in place with a contact lens.  A standard ISCEV protocol was used 
which recorded scotopic responses before a 10 min light adaption phase in order to 
record photopic responses.  3 cd.s/m2 light intensity scotopic responses were used for 
analysis. 
Extracellular Flux Analysis 
Mitochondrial activity of Mouse Embryonic Fibroblast (MEF) cells was analysed using 
the Seahorse Extracellular Flux Analyser, XFe24 (Agilent) as described in (Lee et al., 
2016).  Cells were seeded into a 24 well plate, 15,000 per well, the day before so cells 
were 90% confluent at the time of the assay (mutant cell lines appear to proliferate at 
same rate as control cells).  Oxygen consumption (OCR) was measured from cells in XF 
Assay media supplemented with 10mM Glucose and 2mM pyruvate (pH adjusted to 
7.4 at 37°C). After 3 basal OCR measurements were obtained, OCR was measured 
following sequential injection of mitochondrial drugs (3 measurements per drug 
injection); Oligomycin (Port A, 1 µM), FCCP (Port B – 3.5 µM), Antimycin and Rotenone 
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 (Port C, 1 µM). Each measurement was derived from the rate of change in oxygen 
following a standard protocol (Mix: 3minutes, Wait: 2 minutes, Measure: 3 minutes). 
Results were then standardized to cell number by Sulforhodamine B assay, and results 
were reported by 540 absorption.   
Optokinetic Reflex Measurement 
We assessed the visual acuity of the mice in the ENU screen using a virtual reality 
optokinetic system as described by (Douglas et al., 2005) and manufactured by 
Cerebral Mechanics Inc (cerebralmechanics.com). In brief we observe the head 
tracking response of the mouse to a variable density moving grating. The mouse is 
positioned within a cabinet formed of monitors on which a virtual drum made of a 
vertical grating is generated by computer. The grating density is varied to determine 
the point at which the head tracking stops, showing the grating is no longer perceived. 
Structural Analysis 
The effects of the missense mutations on the crystal structure of the IDH3α:IDH3γ 
heterodimer (PDB ID: 5GRI) (Ma et al., 2017a) were modelled using the program 
FoldX(Guerois et al., 2002). The predicted effect on monomer stability (ΔΔG) was 
calculated with the FoldX BuildModel function, using the IDH3A subunit in isolation 
from the complex. The predicted change in interaction strength was calculated as the 
difference between the change in stability for the heterodimeric complex and the 
monomer. 
Western Blot 
Protein samples were ran on a 4-12% Tris-Bis gel (Invitrogen) and transferred onto a 
PVDF membrane.  Alpha-tubulin (T5168, Sigma), Total OXPHOS (ab110413, Abcam), 
Idh3a (15909-1-AP, Proteintech) and Idh3b (ab121016, Abcam) were all diluted 
1:1000 in PBS with 5% marvel and incubated overnight at 4°C.  Horse radish peroxidase 
conjugate; anti-mouse (NA931V, GE Healthcare Life Sciences), anti-rabbit (NA934V, 
GE Healthcare Life Sciences) and anti-goat (SC-2020, Santa Cruz) were diluted 1:7000 
in  PBS with 5% marvel and incubated at room temperature for 1 hour.   
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Reactive Oxygen Species Detection 
An Image-iTTM LIVE Green Reactive Oxygen Species Detection Kit (I36007, Invitrogen) 
was used as per manufacturer’s instructions.  Cells were imaged using a Nikon A1R 
microscope and analysis of fluorescent levels was done using ImageJ and normalized 
to DAPI fluorescent levels.  
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 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Idh3aE229k/E229K mice exhibit signs of retinal degeneration 
(A) Idh3aE229K/E229K (red) showed a decline in visual acuity by 12 months (0.2071 
± 0.01872 c/d (mean±SEM, n= 9, F4, M5)) compared to wild type (blue) (0.3090 ± 
0.009441 c/d (mean±SEM, n= 23,F14, M9)) (p < 0.0001) and heterozygous (yellow) 
(0.3173 ± 0.007472 c/d (mean±SEM, n= 35, F24, M11)) (p < 0.0001). This significant 
decline continued and by 18 months homozygous mice had degenerated further 
(0.1592 ± 0.02396 c/d (mean±SEM, n= 9 F4, M5)) compared to wild type (blue) (0.3004 
± 0.01223 c/d (mean±SEM, n= 23 F14, M9)) (p < 0.0001) and heterozygous (yellow) 
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 (0.2836 ± 0.009699 c/d (mean±SEM, n= 35 F24, M11)) (p < 0.0001). (B) Fundus 
imaging comparing Idh3aE229K/E229K retinas to wild type littermate; mutant retina 
exhibits signs of retinal degeneration as evidenced by dark patchy appearance.  
Unpaired Ttest ***p < 0.001.  (C) Structure of the IDH3A:IDH3G heterodimer (PDB 
ID: 5GRI) with the positions of the E229K mutation identified in this study (red) and 
previously identified missense mutations (blue) highlighted. (D) Predicted effects of 
mutations on the stability of the IDH3A monomer and on the strength of the 
interaction with IDH3G. Higher values indicate greater disruption of protein stability 
or interaction strength. 
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Figure 2 Idh3a-/E229K and Idh3aE229K/E229K mice show early and rapid 
photoreceptor loss 
(A) In Idh3a-/E229K mice reactive gliosis, indicated by green GFAP staining, is 
present from P30 and continues through P60-90, wildtype littermate control 
also shown (n=3).  In Idh3aE229K/E229K retinas, this staining is not present in P30 – 
60, or in wildtype littermates but is seen in P90 retinal sections (n=3). Blue 
staining is DAPI. (B) Histological analysis of Heamatoxylin and Eosin stained 
eyes. The numbers of nuclei in the ONL are clearly decreased in Idh3a-/E229K at 
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 P60 and almost absent by P90. (C-D) Numbers of photoreceptor nuclei in the 
outer nuclei layer (Y-axis) at fixed distances either side of the optic nerve head 
(X-axis). (C) Counts at 30 days shows that all genotypes have normal nuclei 
numbers, except for the periphery of Idh3a-/E229K retinas (n=3-6, data in Table 
S2). By P60 and continuing to P90 (D) the numbers of nuclei are significantly 
decreased in Idh3aE229K/E229K retinas  (n=7 F7,M2) compared to wild type 
littermate controls (n=7 F4,M3). Unpaired T-test *p < 0.05 **p < 0.01 Scale bar 
50µm. Retinal Ganglion Cell (RGC) layer, Inner Nuclei Layer (INL), Outer Nuclei 
Layer (ONL) and Retinal Pigmented Epithelium (RPE) layer labelled.  
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Figure 3 Idh3a-/E229K and Idh3aE229K/E229K mice show normal then decreased 
photoreceptor function 
(A-B) A-wave amplitudes of dark adapted Idh3a-/E229K mice and littermate 
controls, exposed to a 3c.d/m3 flash of light at P30 (A) and P60 (B) accompanied 
with traces showing mutant (red) and wild type (blue) scotopic responses at P30 
(top) and P60 (bottom) (C).  At P30 Idh3a-/E229K mice exhibit a-wave amplitudes 
comparable to those of control litter mates shown by one-way ANOVA (3,10) = 
0.7970, p = 0.5232)(n = 4 (F2, M2), 3(F2, M1), 3 (F1, M2), 4 (F2, M2)) but by P60 this 
has significantly decreased (F(3,9) = 32.66, p < 0.001)(n = 3, (M3), 3 (F1, M2), 3 (F1, 
M2), 5, (F1, M4)).  
(D-E) Comparison of a-wave amplitudes between Idh3aE229K/E229K and wild type 
controls at P60 and P120 respectively.  At P60 mutant mice exhibit no loss of retinal 
function (265.5 ± 18.18 (mean±SEM, n= 5 F2, M3)) compared to wild type litter 
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 mates (267.0 ± 21.3 (mean±SEM, n= 4, F4)).  By P120 photoreceptor response to a 
light stimulus is significantly reduced in mutant mice (153.2 ± 35.11 (mean±SEM, n= 
4 F2, M2)) compared to wild type (247.7 ± 15.51 (mean±SEM, n= 4 F3, M1)). 
Accompanying traces (F) show Idh3aE229K/E229K (green) and wild type control traces 
(blue) at P30 (top) and P120 (bottom).  
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Figure 4 Mutant MEF cells exhibit reduced reserve and maximal 
respiration 
Idh3a mutants exhibit reduced mitochondrial maximum respiration and reserve 
capacity.  (A) Oxygen consumption rates (OCR) of MEF cells was measured using 
an Agilent Seahorse XFe24 Extracellular Flux Analyser in basal and stimulated 
conditions.  Histograms show (B) maximal respiration (FCCP measurement 2 – 
Ant/Ret measurement 2), (C) reserve capacity (FCCP measurement 2 – Basal 
measurement 2), (D) basal respiration (Basal measurement 2 – Ant/Ret 
measurement 2), (E) ATP respiration (Basal measurement 2 – Oligo 
measurement 2), (F) leaked respiration (Oligo measurement 2 – Ant/Ret 
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 measurement 2) pmol.min-1.OD540-1 for each part of the experiment (A).  Idh3a-
/E229K and Idh3aE229K/E229K mutant cells show a lower but not significant trend in 
basal, ATP dependent or leaked respiration (D-F).  Both Idh3a-/E229K and 
Idh3aE229k/E229k showed significantly reduced maximum respiration (F(4,10) = 
5.701, p = 0.0118) (B) and spare respiratory capacity (F(4,10) = 6.536, p = 0.0075) 
(C) shown by One-way ANOVA.   
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Figure 5 Idh3b-/- mice show no signs of retinal degeneration up to six 
months 
Idh3b-/- mice show no retinal degeneration up to P180.  (A) GFAP green 
immunofluorescence on retinal sections show no upregulation in mutant mice – 
indicating the absence of retina stress (n=3). ERG analysis of P180 Idh3b-/- in 
response to 3 c.d/m3 flash under scotopic conditions shows a similar a-wave 
amplitude (233.4 ± 19.63 (mean±SEM, n= 6 F2, M4)) to that of wild type litter mates 
(207.7 ± 14.42 (mean±SEM, n= 6 F3, M3)) (B). ERG traces of mutant mice (red) also 
show no defects when compared to wild type (black).  (C-E) OCR was measured in 
Idh3b-/- MEF cells and compared to control litter mates.  In contrast to Idh3a mutant 
cells, Idh3b-/- cells did not show significantly reduced maximum respiration or spare 
respiratory capacity.  (F) Western blot analysis for Idh3b and Alpha tubulin in retina 
tissue shows the absence of Idh3b protein in Idh3b-/- retinas. Scale bar 50µm 
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 Idh3a-/- Idh3a-/+ Idh3a+/+ No. Litters 
Weaned 0 76 44 17 
12.5 0 12 6 3 
10.5 0 9 4 2 
8.5 3 8 2 2 
 
Table 1 Genotyping of loss of function mutant 
 
 
Name Sequence (5’ – 3’) 
Idh3a_Guide A5 GCATTTAAACATACAGTATCA 
Idh3a_Guide B3 GAAGTATGCATCAGTGCTTCC 
Idh3b_Guide 1 AGGAAAGATCTATACCCCAATGG 
 
Table 2 CRISPR Guides 
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 Phenotyping Test  Parameter  
Wild Type  Mutant  
P value+  
Mean  SD  n  Mean  SD  n  
Bodyweight (10w)  
Males(g)  32.17  4.80  46  27.92  5.07  5  0.148  
Females (g)  23.47  3.13  45  23.52  4.51  4  0.984  
Echo MRI  
(3 Months, Males)  
Fat (g)  8.7  3.23  45  5.8  2.70  5  0.076  
Lean (g)  24.5  3.01  45  22.5  4.47  5  0.382  
Fat (%)  23.2  6.21  45  18.0  5.41  5  0.101  
Lean (%)  67.5  5.42  45  72.2  6.49  5  0.194  
Bodyweight (22w)  
Males(g)  38.60  6.14  45  34.22  9.00  5  0.349  
Females (g)  35.69  5.90  45  35.37  7.07  4  0.936  
IPGTT (5 months, 
Males)  
Glucose t=0 (mmol/l)  10.2  2.51  45  8.88  1.41  5  0.115  
Glucose t=60 (mmol/l)  26.5  6.90  45  24.12  4.32  5  0.319  
Glucose t=120 (mmol/l)  17.3  5.40  45  13.68  3.08  5  0.058  
Insulin t=0 ( g/l)  1.0  0.40  45  0.875  0.24  5  0.348  
Clinical Chemistry  
(6  months, 
Females)  
Urea (nmol/l)  10.44  3.01  45  8.93  1.21  4  0.085  
Creatinine (µmol/l)  18.19  9.90  45  13.90  4.40  4  0.157  
Calcium (mmol/l)  2.40  0.13  45  2.43  0.06  4  0.439  
ALP (U/l)  89.73  19.52  45  84.40  10.82  4  0.435  
ALT (U/l)  31.18  5.11  45  29.25  2.65  4  0.262  
AST (U/l)  51.21  6.55  45  49.10  9.64  4  0.697  
Albumin (g/l)  33.60  1.93  45  34.90  1.52  4  0.208  
LDH (U/l)  371.99  86.54  45  402.95  68.41  4  0.459  
Amylase (U/l)  595.73  82.96  45  607.35  132.95  4  0.875  
Bodyweight (52w)  Males(g)  46.14  7.85  40  42.72  8.68  5  0.449  
Disease Models & Mechanisms: doi:10.1242/dmm.036426: Supplementary information
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Females (g)  42.69  8.58  44  38.76  11.28  4  0.546  
Clinical Chemistry  
(12  months, 
Females)  
Urea (nmol/l)  9.07  2.34  45  10.80  2.54  4  0.280  
Creatinine (µmol/l)  13.79  6.70  45  21.65  13.90  4  0.345  
Calcium (mmol/l)  2.36  0.37  45  2.38  0.22  4  0.879  
ALP (U/l)  98.68  31.09  45  85.90  12.80  4  0.157  
ALT (U/l)  37.31  16.45  45  37.20  4.79  4  0.975  
AST (U/l)  61.89  21.77  45  64.95  24.42  4  0.824  
Albumin (g/l)  33.74  5.39  45  36.35  1.67  4  0.048*  
 LDH (U/l)  411.96  220.92  45  877.90  773.73  4  0.316  
Amylase (U/l)  610.81  141.53  45  531.25  112.70  4  0.278  
Bodyweight (78w)  
Males(g)  47.20  7.69  22  41.31  6.36  4  0.175  
Females (g)  46.16  9.84  21  42.44  13.86  4  0.643  
Clinical Chemistry  
(18  months, 
Females)  
Sodium (mmol/l)  150.82  3.70  40  152.50  104.03  4  0.976  
Potassium (mmol/l)  6.32  1.81  40  7.78  3.19  4  0.434  
Chloride (mmol/l)  107.49  2.93  40  109.25  73.93  4  0.965  
Urea (nmol/l)  9.71  1.91  40  8.50  5.52  4  0.962  
Creatinine (µmol/l)  13.41  3.64  40  12.15  6.91  4  0.743  
Calcium (mmol/l)  2.42  0.23  40  2.41  1.55  4  0.991  
Inorganic Phosphate (mmol/l)  2.50  0.87  40  2.93  1.15  4  0.520  
ALP (U/l)  94.62  37.87  40  99.00  40.13  4  0.848  
ALT (U/l)  42.36  30.20  40  37.50  8.59  4  0.463  
AST (U/l)  83.87  46.77  40  70.50  26.23  4  0.415  
Total Protein (g/l)  53.20  3.09  40  53.18  35.43  4  0.999  
Albumin (g/l)  28.41  1.96  40  31.15  18.70  4  0.789  
Total Cholesterol (mmol/l)  4.40  0.96  40  3.73  2.43  4  0.622  
HDL (mmol/l)  2.86  0.58  40  2.48  1.61  4  0.671  
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LDL (mmol/l)  0.91  0.34  40  1.00  0.40  4  0.693  
Glucose (mmol/l)  16.16  5.41  40  14.11  7.60  4  0.635  
Triglycerides (mmol/l)  1.95  0.75  40  1.87  0.85  4  0.868  
Glycerol (µmol/l)  574.51  222.14  40  685.00  249.17  4  0.456  
Free Fatty Acids (mmol/l)  1.22  0.38  40  1.69  0.60  4  0.222  
Total Bilirubin (µmol/l)  2.29  0.42  40  4.28  1.32  4  0.058  
LDH (U/l)  498.79  164.06  40  520.50  236.69  4  0.869  
Amylase (U/l)  608.15  86.25  40  521.75  369.04  4  0.672  
Creatine Kinase (U/I  169.54  160.17  40  219.00  6.63  4  0.060  
Uric Acid (µmol/l)  278.65  134.67  40  380.67  101.81  4  0.138  
Fructosamine (µmol/l)  228.62  44.81  40  173.25  129.97  4  0.459  
 
Table S1 Phenotypic analysis of Idh3aE229K/E229K mice   
No significant differences were observed between mutant mice and their wild type littermates apart from the 12 month Albumin concentration, 
however the mutant mice appear to be within normal levels and this was no longer significant by 18 months. +Unpaired T-test with Welch’s correction,  
* p < 0.05  
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 Mouse Sex MPC Idh3a 
Periphery 
1 
middle 
1 
nerve 
1 nerve2 
middle 
2 
periphery 
2 
1002 M WT MUT 9 9.2 9.4 11.2 10.8 9.4 
1003 M MUT MUT 9 10.6 8.8 9.4 8.2 6.2 
1004 M WT WT 9 12.4 11.4 10 11.2 8.4 
1005 M WT WT 9.6 11.2 10.2 11.4 11.2 9.4 
1006 M WT MUT 9.4 11.6 10.6 11.6 10.6 8.6 
1007 F MUT MUT 6.2 9.2 9.4 8.6 8.8 6.4 
1008 F WT WT 7.2 9.6 10.8 11.2 11.2 8.8 
1009 F WT WT 9.4 11.4 9.8 10.4 11.4 9.8 
1010 F WT MUT 8.8 11.6 10 9.2 11.4 9 
1202 M MUT WT 11.2 12.4 10 10.2 10 10.2 
1203 M MUT WT 8 11.6 11.4 9.4 10.4 9.6 
1204 M WT MUT 11 12.4 10 11.4 11.6 10.2 
1205 M MUT MUT 8 11.4 10.2 11.2 10.4 8.6 
1206 F WT MUT 9.2 12.2 12.8 11.4 10.4 9 
1207 F WT MUT 9.6 10.4 10.2 10.6 10.4 10.2 
1208 F WT WT 9.2 11.2 12.2 10.6 9.2 8.2 
1209 F MUT MUT 7 10.6 10.6 10.6 10 8.8 
1210 F WT WT 7.8 8.2 10.4 11 11 9 
1211 F MUT WT 10 10.4 10.6 10.6 10.8 8.4 
 
Table S2. Outer nuclear layers of offspring of Idh3a E229K/- intercross. WT and MUT indicate wild-type or mutant for the particular allele. Number of 
nuclei in sections through the outer nuclear layer. Each is the mean of 5 counts (technical replicates).  
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 Genotype Average Fluorescence Intensity 
 
Cell line 
1 
Cell line 
2 
Cell line 
3 
Cell line 
4 
+/+ 203.128 263.989 264.796 278.359 
E229K/+ 322.033 294.909 327.883  
-/+ 292.315 262.582 250.29 258.325 
E229K/E229K 230.348 272.818 265.045 222.117 
-/E229K 360 216.375 267.474  
 
Table S3 Reactive Oxygen Species: Data for Figure S3. 3 or 4 cell lines (biological replicates) from each genotype were analysed with measurements in 4 
wells (technical replicates). The means of the technical replicates are shown for each biological replicate. 
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Figure S1 Analysis of Idh3a expression and protein levels in mutant MEF cells 
(A) RNA was isolated from C57BL6/J mice retina and brain and RT-PCR was performed to assay the expression of Idh3 heterotetramer components and 
Idh2 genes.  All were present in all samples. (B) Western blot showing the reduced protein in Idh3a-/+ and Idh3a-/E229K compared to control littermates 
(Idh3a+/+ and Idh3aE229K/E229K) as well as Idh3aE229K/E229K mutant cells.  Alpha-tubulin was used as a loading control. 
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Figure S2 Analysis of Idh3a-/+ mice show no retinal phenotype up to one year 
(A) Idh3a-/+ mice show no upregulation of GFAP at one year, with staining comparable to that of wild type littermates (n = 3). (B) Morphology of retinal 
layers, including the outer nuclear layer, appears normal at 12 months and is comparable to that of wild type littermates (n = 6). (C) Idh3a-/+ mutant 
mice show no reduction in retinal function at one year, exhibiting similar ERG a-wave responses to those of wild type littermates (p = 0.286, n = 4). 
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Figure S3 Further analysis of MEF cell lines 
(A) Reactive Oxygen Species (ROS) were measured in each of the cell lines, both Idh3a-/E229K and Idh3aE229K/E229K cells showed levels similar to that of 
control cells (Idh3a+/+, Idh3a-/+ and Idh3aE229K/+), graph shows fluorescent intensity in arbitrary units Data is in Table S3. (B) Western blot analysis of MEF 
cell lines showing similar levels of mitochondrial proteins; Complex II, Complex IV and Complex V.  Alpha-tubulin was used as a loading control. 
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